We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

176 hedge funds and large institutions have $1.23B invested in Acorda Therapeutics in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 50 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 50

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

4% more funds holding

Funds holding: 170 → 176 (+6)

19% less capital invested

Capital invested by funds: $1.51B → $1.23B (-$283M)

75% less call options, than puts

Call options by funds: $2.15M | Put options by funds: $8.69M

Holders
176
Holders Change
+6
Holders Change %
+3.53%
% of All Funds
4.91%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
28
Increased
69
Reduced
50
Closed
21
Calls
$2.15M
Puts
$8.69M
Net Calls
-$6.55M
Net Calls Change
-$6.55M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$35M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$25.9M
3
SCM
Scopia Capital Management
New York
+$18.3M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$16.5M
5
Millennium Management
Millennium Management
New York
+$13.7M

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$56.1M
2
TCM
Tekla Capital Management
Massachusetts
-$22.7M
3
EAM
Eagle Asset Management
Florida
-$13.7M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$9.87M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
JGC
26
J. Goldman & Co
New York
$9.6M +$11.7M +3,018 New
VOYA Investment Management
27
VOYA Investment Management
Georgia
$9.04M -$9.87M -2,544 -47%
Norges Bank
28
Norges Bank
Norway
$8.93M – – –
RCAMU
29
Rothschild & Co Asset Management US
Connecticut
$8.91M +$2.31M +595 +27%
PCM
30
Penn Capital Management
Pennsylvania
$8.38M -$2.4M -619 -19%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$7.81M +$101K +26 +1%
Barclays
32
Barclays
United Kingdom
$7.21M +$8.93M +2,303 +32,900%
Ameriprise
33
Ameriprise
Minnesota
$7.17M +$1.84M +474 +27%
SFM
34
Sphera Funds Management
Israel
$7.16M +$3.88M +1,000 +80%
Principal Financial Group
35
Principal Financial Group
Iowa
$7.15M +$46.5K +12 +0.5%
Bank of America
36
Bank of America
North Carolina
$7.1M +$1.19M +306 +16%
JP Morgan Chase
37
JP Morgan Chase
New York
$7.04M +$77.6K +20 +0.9%
SAM
38
Senzar Asset Management
New York
$7.02M +$8.56M +2,206 New
Balyasny Asset Management
39
Balyasny Asset Management
Illinois
$6.74M +$4.55M +1,174 +124%
American Century Companies
40
American Century Companies
Missouri
$5.67M +$1.55M +399 +29%
GC
41
Guggenheim Capital
Illinois
$5.1M -$248K -64 -4%
TA
42
Teachers Advisors
New York
$4.93M -$2.88M -743 -32%
Public Employees Retirement Association of Colorado
43
Public Employees Retirement Association of Colorado
Colorado
$4.62M +$465K +120 +9%
TCIM
44
TIAA CREF Investment Management
New York
$4.61M -$589K -152 -10%
TRSOTSOK
45
Teachers Retirement System of the State of Kentucky
Kentucky
$4.37M -$4.75M -1,225 -47%
SO
46
STRS Ohio
Ohio
$4.34M +$396K +102 +8%
BIM
47
BlackRock Investment Management
Delaware
$4.33M -$54.3K -14 -1%
PAM
48
Panagora Asset Management
Massachusetts
$4.21M – – –
EAM
49
EverPoint Asset Management
Connecticut
$3.98M +$4.85M +1,250 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$3.92M -$1.91M -493 -29%
1
2
3 4 5

ACOR Hedge Fund Activity: Q3 2015 in Review

176 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2015, worth a combined $1.23B — down 19% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 21 closed out — a net gain of 7 holders — while 69 added to existing stakes and 50 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $35M. The largest seller was UBS AM, cutting an estimated $56.1M.

  • 176 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2015, up from 170 in Q2 2015.
  • Funds reported $1.23B of Acorda Therapeutics stock for Q3 2015, down 19% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q3 2015 and 21 closed out, a net change of +7 holders.
  • The largest Acorda Therapeutics buyer in Q3 2015 was Point72 Asset Management, an estimated $35M added.
  • The largest Acorda Therapeutics seller in Q3 2015 was UBS AM, an estimated $56.1M sold.

Based on aggregated 13F filings for Q3 2015.